Bilcare P/B Ratio
Bilcare (BI) P/B ratio is 0.74 (Low), book value per share ₹82.08 vs Healthcare average P/B of -0.3 — Low - Trading below book value, may indicate undervaluation. Review BI PE ratio trends to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
BI P/B Ratio — Valuation Insights & Book Value Analysis
Bilcare price-to-book ratio interpretation, valuation status and historical context — current P/B 0.74 (Low). View BI 52-week performance for the annual high/low range and current price position.
- Stock appears undervalued with PB of 0.74, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 74.5% above historical average
- Trading at premium to sector average PB of -0.3
Bilcare P/B Ratio Historical Trend
BI annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Bilcare share price screener.
BI Historical P/B Ratio — Book Value Per Share & Year-End Price
Bilcare annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.72 | ₹82.08 | ₹59.27 | ₹197 | Low |
| 2025 | 0.32 | ₹245.83 | ₹79.67 | ₹590 | Low |
| 2024 | 0.24 | ₹269.17 | ₹65.57 | ₹646 | Low |
| 2023 | 0.27 | ₹293.33 | ₹79.03 | ₹704 | Low |
| 2022 | 0.57 | ₹67.08 | ₹38.00 | ₹161 | Low |
BI vs Healthcare Peers — P/B Ratio Comparison
Bilcare P/B 0.74 vs Healthcare average -0.3, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |